Listed by the USPTO as MAEWALL, SNIGDHA
Tech Center 1600 • Art Units: 1612
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18257187 | PROCESS FOR PREPARING MICROCAPSULES | Final Rejection | SYNGENTA CROP PROTECTION AG |
| 18251816 | AGROCHEMICAL COMPOSITION WITH IMPROVED DRIFT, SPREADING AND RAINFASTNESS PROPERTIES | Final Rejection | Bayer Aktiengesellschaft |
| 18852338 | COSMETIC | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 18269626 | Antiviral formulation, antiviral filtering material, methods of preparation thereof and antiviral face mask | Non-Final OA | ArcelorMittal |
| 18578443 | HYDRATABLE CONCENTRATED SURFACTANT COMPOSITIONS | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy58.8% of resolved applications examined by Snigdha Maewall were allowed (1,072 resolved cases), compared with 40.7% across Art Unit 1612 over the last five years.
This examiner's interview lift is +10.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Snigdha Maewall took 1,236 days on average from filing to allowance.
Snigdha Maewall examines applications in Art Unit 1612 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
